Analogic (ALOG) Stock Price, News & Analysis

Company Overview

Analogic Corporation designs, manufactures, and sells medical imaging systems, ultrasound and security systems, and subsystems to original equipment manufacturers (OEMs) and end users primarily for the medical and airport security markets worldwide. It operates in three segments: Medical Imaging, Ultrasound, and Security and Detection. The Medical Imaging segment offers computed tomography (CT) detector systems, data acquisition systems, data management systems, and integrated CT systems; magnetic resonance imaging products, including gradient and radio frequency amplifiers; and digital mammography products, such as detector plates, as well as motion control devices for use in computer-controlled automation systems primarily for the semiconductor, food and beverage, and laboratory automation markets. This segment sells its products through multinational OEMs. The Ultrasound segment designs and manufactures medical ultrasound systems under the BK Ultrasound brand for use in urology, surgery, point-of-care, anesthesia, and general imaging applications. It also provides its products for cardiology, radiology, OB/GYN, surgery, and interventional radiology applications, as well as offers various transducers. This segment sells its products through its direct sales force, as well as through a network of independent sales representatives and distributors. The Security and Detection segment designs and manufactures automated threat detection systems for aviation baggage inspection applications. It provides checked baggage, checkpoint CT, and high speed in-line baggage handling systems; and rapid DNA analysis systems to analyze multiple human DNA samples. This segment sells its products primarily through multinational partners. Analogic Corporation has a partnership agreement with Stratovan Corporation. The company was founded in 1967 and is headquartered in Peabody, Massachusetts.

Key Stats

• Today's Range: $83.95 to $84.00
• 50-Day Range: N/A
• 52-Week Range: $67.85 to $101.80
• Volume: 212,601 shs
• Average Volume: 217,928 shs
• Market Capitalization: N/A
• P/E Ratio: 18.05
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ALOG Stock Analysis - Frequently Asked Questions

How were Analogic's earnings last quarter?

Analogic Co. (NASDAQ:ALOG) announced its quarterly earnings data on Monday, June, 4th. The medical research company reported $1.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.97 by $0.11. The medical research company earned $119.97 million during the quarter, compared to the consensus estimate of $113.60 million.

What other stocks do shareholders of Analogic own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Analogic investors own include Intercept Pharmaceuticals (ICPT), Exelixis (EXEL), Amicus Therapeutics (FOLD), Global Blood Therapeutics (GBT), Madrigal Pharmaceuticals (MDGL), NovoCure (NVCR) and Abaxis (ABAX).

Company Calendar

• Last Earnings: 6/04/2018
• Today: 8/25/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Computer and Technology
• Industry: Instruments To Measure Electricity
• Sub-Industry: Health Care Equipment
• Current Symbol: NASDAQ:ALOG
• CIK: 6284
• Web: www.analogic.com
• Phone: 978-326-4000
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 18.05
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Optionable
• Beta: N/A